on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
On July 15, 2025, Oxurion NV, a biopharmaceutical company located in Leuven, Belgium, announced it had received a transparency notification, in line with Belgian legislation, from Atlas Special Opportunities II, LLC. The notification indicated that as of July 14, 2025, Atlas held 2,751,917 shares of Oxurion, representing a reduction below the 25% threshold of the company's 12,428,021 outstanding shares. This change is due to the selling of voting securities by Atlas.
The notification aligns with Article 14 of the Law of May 2, 2007, focusing on disclosure of significant holdings. Oxurion continues to align its operations with regulatory requirements while advancing its biotechnological innovations.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news